Breaking News Instant updates and real-time market news.

PRU

Prudential

$92.81

-0.52 (-0.56%)

04:55
11/14/19
11/14
04:55
11/14/19
04:55

Prudential management to meet with RBC Capital

Meetings to be held in Ft. Lauderdale, FL on November 13 and in Orlando, FL on November 14 hosted by RBC Capital.

  • 14

    Nov

PRU Prudential
$92.81

-0.52 (-0.56%)

11/05/19
WELS
11/05/19
DOWNGRADE
Target $92
WELS
Market Perform
Prudential downgraded to Market Perform at Wells Fargo, price target cut to $92
Wells Fargo analyst Elyse Greenspan downgraded Prudential to Market Perform from Outperform with a price target of $92, down from $105. In a research note to investors, Greenspan notes that the company's quarterly EPS of $3.22 handily beat estimates, but notes that this was the second quarter in a row where earnings have been re-based lower. Greenspan says she is using this as an opportunity to move to the sidelines. While Prudential has been working on its financial wellness initiatives, which should improve its margin and return prospects, the analyst states that the positive impact of these initiatives will not start to be felt in numbers until late next year.
11/05/19
11/05/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Buy from Conviction Buy at Goldman Sachs and to Neutral from Outperform at Baird. 2. Hudson (HUD) downgraded to Underperform from Neutral at BofA/Merrill with analyst Marisa Sullivan saying after a "disappointing" set of Q3 results and Q4 guidance, she sees an "increasingly uncertain" outlook for the company's core business despite the contributions being made from the OHM and Brookstone acquisitions. 3. Stryker (SYK) downgraded to Equal Weight from Overweight at Barclays with analyst Kristen Stewart saying while Stryker remains a "strong company fundamentally," the stock's performance over the next year is likely to be restrained by the outstanding Wright Medical Group (WMGI)m which is not expected to close until Q3 of 2020. 4. U.S. Steel (X) downgraded to Hold from Buy at Argus with analyst David Coleman saying its Q3 earnings came in "significantly short" relative to his estimates. 5. Prudential (PRU) downgraded to Market Perform from Outperform at Wells Fargo with analyst Elyse Greenspan saying the company's quarterly EPS of $3.22 handily beat estimates, but this was the second quarter in a row where earnings have been re-based lower. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/05/19
KBWI
11/05/19
DOWNGRADE
Target $102
KBWI
Market Perform
Prudential downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Ryan Krueger downgraded Prudential to Market Perform from Outperform with a price target of $102, down from $107. To reflect softer business growth and lower individual annuity margins, the analyst further reduced his estimates for Prudential. He now forecasts an intermediate-term return on equity towards the low-end of the company's 12%-14% target and more in-line with peers. Prudential's interest rate sensitivity is greater than anticipated, says Krueger, who does not expect the company's cost save actions to meaningfully contribute until 2022.
11/06/19
11/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Groupon (GRPN) downgraded to Underweight from Neutral at JPMorgan with analyst Doug Anmuth saying while he is encouraged by the company's efforts toward improving customer conversion, he thinks those efforts will take time to offset traffic and international macro headwinds. 2. Altice USA (ATUS) downgraded to Sector Weight from Overweight at KeyBanc and to Equal Weight from Overweight at Barclays. 3. Prudential (PRU) downgraded to Market Perform from Outperform at Keefe Bruyette with analyst Ryan Krueger saying to reflect softer business growth and lower individual annuity margins, he further reduced his estimates for Prudential. 4. KeyCorp (KEY) downgraded to Neutral from Outperform at Baird with analyst David George saying shares have reached his price target and although he is comfortable with the company outlook, he would wait for a better entry point for the shares. George maintained his $19 price target on KeyCorp shares. 5. WW (WW) downgraded to Neutral from Buy at DA Davidson with analyst Linda Weiser saying subscribers exceeded her estimate in the quarter, but that did not translate to gross margin upside, which is concerning given the dampening effect on sales of the studio to digital shift. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

COST

Costco

$297.17

1.95 (0.66%)

14:49
12/12/19
12/12
14:49
12/12/19
14:49
Options
Costco options imply 5.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NVST

Envista

$28.37

0.19 (0.67%)

14:45
12/12/19
12/12
14:45
12/12/19
14:45
Options
Envista Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRX

Brixmor

$21.07

-0.36 (-1.68%)

14:44
12/12/19
12/12
14:44
12/12/19
14:44
Conference/Events
Brixmor management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 11

    Feb

PD

PagerDuty

$22.13

-0.235 (-1.05%)

14:40
12/12/19
12/12
14:40
12/12/19
14:40
Conference/Events
PagerDuty management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

SPY

SPDR S&P 500 ETF Trust

$315.97

1.56 (0.50%)

, SPX

S&P 500

$0.00

(0.00%)

14:39
12/12/19
12/12
14:39
12/12/19
14:39
Periodicals
U.S. negotiators reach China trade deal, pending Trump approval, Bloomberg says »

U.S. negotiators have…

SPY

SPDR S&P 500 ETF Trust

$315.97

1.56 (0.50%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,752.74

3.63 (0.21%)

14:34
12/12/19
12/12
14:34
12/12/19
14:34
Periodicals
Amazon to open distribution center in Pernambuco, Brazil in 2020, Reuters says »

Amazon said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$316.10

1.69 (0.54%)

, SPX

S&P 500

$0.00

(0.00%)

14:34
12/12/19
12/12
14:34
12/12/19
14:34
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

U.S. has deal 'in…

SPY

SPDR S&P 500 ETF Trust

$316.10

1.69 (0.54%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMNFF

MedMen

$0.00

(0.00%)

14:25
12/12/19
12/12
14:25
12/12/19
14:25
Conference/Events
MedMen management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FB

Facebook

$200.86

-1.37 (-0.68%)

14:22
12/12/19
12/12
14:22
12/12/19
14:22
Periodicals
FTC considers injunction to block Facebook policies on app integration, WSJ says »

The Federal Trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$5.00

1.515 (43.47%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUV

Southwest

$54.65

0.67 (1.24%)

, BA

Boeing

$346.36

-3.64 (-1.04%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Periodicals
Southwest weighs another delay in 737 MAX's return to schedule, Bloomberg says »

Southwest Airlines (LUV)…

LUV

Southwest

$54.65

0.67 (1.24%)

BA

Boeing

$346.36

-3.64 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$200.80

-1.43 (-0.71%)

14:16
12/12/19
12/12
14:16
12/12/19
14:16
Periodicals
FTC considering injunction against Facebook, WSJ says »

The potential FTC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/12/19
12/12
14:16
12/12/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$12.67

0.53 (4.37%)

14:15
12/12/19
12/12
14:15
12/12/19
14:15
Options
Intra Cellular Therapies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Dec

TISI

Team

$15.98

-0.03 (-0.19%)

14:14
12/12/19
12/12
14:14
12/12/19
14:14
Initiation
Team initiated  »

Team initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$39.37

-0.12 (-0.30%)

, MO

Altria Group

$50.38

0.075 (0.15%)

14:11
12/12/19
12/12
14:11
12/12/19
14:11
Periodicals
CDC says many brands likely responsible for vaping-related injuries, Verge says »

The Centers for Disease…

BTI

British American Tobacco

$39.37

-0.12 (-0.30%)

MO

Altria Group

$50.38

0.075 (0.15%)

PM

Philip Morris

$84.20

-0.8 (-0.94%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NXGN

NextGen Healthcare

$17.10

-1.01 (-5.58%)

14:11
12/12/19
12/12
14:11
12/12/19
14:11
Hot Stocks
NextGen Healthcare down 6% after guiding 'relatively flat' earnings until FY23 »

In presentation slides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AMRX

Amneal Pharmaceuticals

$5.04

1.555 (44.62%)

14:09
12/12/19
12/12
14:09
12/12/19
14:09
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXGN

NextGen Healthcare

$17.39

-0.72 (-3.98%)

14:08
12/12/19
12/12
14:08
12/12/19
14:08
Earnings
NextGen Healthcare lowers FY20 EPS outlook, raises low-end of FY20 revenue view »

In presentation slides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

APO

Apollo Global

$44.31

-0.66 (-1.47%)

, GE

General Electric

$11.36

0.375 (3.42%)

14:06
12/12/19
12/12
14:06
12/12/19
14:06
Hot Stocks
Apollo, Athene close the acquisition of GE Capital's PK AirFinance debt business »

Apollo Global Management…

APO

Apollo Global

$44.31

-0.66 (-1.47%)

GE

General Electric

$11.36

0.375 (3.42%)

ATH

Athene Holding

$45.09

1.12 (2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 26

    Feb

CIEN

Ciena

$41.74

6.29 (17.74%)

14:06
12/12/19
12/12
14:06
12/12/19
14:06
Recommendations
Ciena analyst commentary  »

Ciena's long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BMRN

BioMarin

$80.03

1.25 (1.59%)

14:05
12/12/19
12/12
14:05
12/12/19
14:05
Options
BioMarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

, AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

13:59
12/12/19
12/12
13:59
12/12/19
13:59
Recommendations
TherapeuticsMD, Amneal Pharmaceuticals, Merck analyst commentary  »

Stifel says…

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

MRK

Merck

$89.27

0.31 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

HURN

Huron

$69.15

0.23 (0.33%)

13:57
12/12/19
12/12
13:57
12/12/19
13:57
Conference/Events
Huron management to meet with Benchmark »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.